News
On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...
Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...
The Swiss pharmaceutical giant plans to build seven new facilities and expand others in an effort that will allow it to ...
Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...
Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...
Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...
Swiss pharmaceutical giant Novartis AG said it would invest $23 billion in the US over the next five years to ensure its key ...
Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...
Novartis (NVS, Financials) is investing $23 billion over the next five years to expand its manufacturing and research ...
NEW YORK] Swiss pharmaceutical giant Novartis said it would invest US$23 billion in the US over the next five years to ensure ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results